XIAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of XIAP Antibodies for research in apoptosis regulation and cellular signaling pathways. XIAP Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). X-linked inhibitor of apoptosis protein (XIAP) plays a critical role in inhibiting apoptosis by binding to and inhibiting caspases, which are essential for the execution of programmed cell death. XIAP dysregulation has been implicated in various diseases, including cancer, making it a significant target for therapeutic intervention. Understanding the function and regulation of XIAP is crucial for advancing knowledge of cell survival mechanisms and developing potential treatments for apoptosis-related disorders. XIAP research has revealed important insights into cellular death pathways and their regulation in normal and pathological conditions. Investigating XIAP interactions with other proteins has enhanced understanding of apoptosis signaling networks. Recent studies have highlighted XIAP's potential as a biomarker for disease progression and treatment response. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of XIAP's role in cellular processes and disease development.